PHARMAGELLAN Trademark

Trademark Overview


On Thursday, February 5, 2015, a trademark application was filed for PHARMAGELLAN with the United States Patent and Trademark Office. The USPTO has given the PHARMAGELLAN trademark a serial number of 86525295. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, December 27, 2024. This trademark is owned by Pharmagellan, LLC. The PHARMAGELLAN trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business management and consultation; Business management and consultation in the field of life sciences, biotechnology, medical devices, pharmaceuticals and healthcare.; Business management consulting, strategic planning and business advisory services provided to companies and innovators in the field of life sciences, biotechnology, medical devices, pharmaceuticals and healthcare
pharmagellan

General Information


Serial Number86525295
Word MarkPHARMAGELLAN
Filing DateThursday, February 5, 2015
Status800 - REGISTERED AND RENEWED
Status DateFriday, December 27, 2024
Registration Number4808280
Registration DateTuesday, September 8, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 23, 2015

Trademark Statements


Goods and ServicesBusiness management and consultation; Business management and consultation in the field of life sciences, biotechnology, medical devices, pharmaceuticals and healthcare.; Business management consulting, strategic planning and business advisory services provided to companies and innovators in the field of life sciences, biotechnology, medical devices, pharmaceuticals and healthcare

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, February 18, 2015
Primary Code035
First Use Anywhere DateSunday, December 8, 2013
First Use In Commerce DateSunday, December 8, 2013

Trademark Owner History


Party NamePharmagellan, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressWellesley, MA 02481

Party NamePharmagellan, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWellesley, MA 02481

Party NamePharmagellan, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWellesley, MA 02481

Trademark Events


Event DateEvent Description
Wednesday, February 18, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 9, 2015NEW APPLICATION ENTERED
Tuesday, September 8, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, July 22, 2021TEAS SECTION 8 & 15 RECEIVED
Tuesday, May 12, 2015ASSIGNED TO EXAMINER
Tuesday, May 12, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 3, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 23, 2015PUBLISHED FOR OPPOSITION
Tuesday, June 23, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 8, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, May 7, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 7, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, September 8, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, December 27, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, December 27, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, December 27, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, December 27, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, September 13, 2024TEAS SECTION 8 & 9 RECEIVED
Saturday, October 30, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, October 30, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, October 30, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED